MILESTONE SCIENTIFIC INC.
MLSSNYSEHealthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $9.0M | $8.6M | $9.8M | $8.8M | $10.3M | $5.4M |
| Operating income | −$5.7M | −$6.8M | −$7.1M | −$8.8M | −$7.4M | −$7.5M |
| Net income | −$5.7M | −$4.7M | −$6.9M | −$8.7M | −$6.8M | −$7.3M |
| Total assets | $7.8M | $9.8M | $11.4M | $13.7M | $19.8M | $19.6M |
| Total liabilities | $5.0M | $4.0M | $3.4M | $3.7M | $3.6M | $3.5M |
| Equity | $2.8M | $5.8M | $8.0M | $10.2M | $16.4M | $16.2M |
| EPS (diluted) | $-0.07 | $-0.06 | $-0.10 | $-0.12 | $-0.10 | $-0.12 |
| Shares out. | 78.4M | 76.6M | 70.0M | 68.1M | 66.6M | 49.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −63.5%
- Net margin
- −63.8%
- Return on equity
- −203.4%
- Return on assets
- −73.3%
- Return on capital (ROCE)
- −155.0%
- Liabilities / assets
- 64.0%
- Debt / equity
- 1.78×
- Book value / share
- $0.04
- Revenue growth (YoY)
- 4.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -57.37distress
- Accruals / assets
- −35.9%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 28, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2016
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2015
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2007
- NT 10-Qmissed a reporting deadline ↗May 16, 2007
- NT 10-Kmissed a reporting deadline ↗Apr 3, 2006
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Bp4 S.R.L.Activist (13D)Feb 7, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.1M | 1.5 | -58.0% |
| Apr 30, 2026 | 2.5M | 1.8 | +333.2% |
| Apr 15, 2026 | 584,975 | 1.0 | +622.4% |
| Mar 31, 2026 | 80,981 | 1.0 | -36.8% |
| Mar 13, 2026 | 128,116 | 1.4 | -22.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Changed auditorMay 6, 2026
- Director / officer changeMay 6, 2026
- Entered a material agreement · Unregistered equity saleApr 21, 2026
- Entered a material agreementApr 2, 2026
- Amended charter or bylawsMar 11, 2026
- Entered a material agreementJan 20, 2026
- Shareholder voteDec 23, 2025
- Director / officer changeNov 13, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.